Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.
Neuro42 has raised $15.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
Neuro42's investors include Shangbay Capital, Zepp, Zynext Ventures, National Institute of Neurological Disorders and Stroke, Fred Moll, M.D.
Neuro42 is headquartered in San Francisco, United States.
Neuro42 is developing and commercializing advanced MRI and robotics technology for diagnosis and image-guided interventions.
Neuro42 is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neuro42 — Funding & Investors." VCBacked, August 15, 2024, https://www.vcbacked.co/company/neuro42. Accessed August 15, 2026.
VCBacked. (2024). Neuro42 — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/neuro42
{{cite web |title=Neuro42 — Funding & Investors |url=https://www.vcbacked.co/company/neuro42 |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated